日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

US EUROPE AFRICA ASIA 中文
Business / Companies

Guilin at forefront in battle against malaria

By Wang Hongyi (China Daily) Updated: 2015-11-09 09:47

Since 2000, global mortality rates among malaria patients have dropped by 47 percent. In Africa, the rate has come down by 54 percent for adults and 58 percent for children.

GPSC has played an important role, along with major global pharmaceutical companies such as Novartis in Switzerland and Sanofi-Aventis in France, in fighting malaria.

The Chinese company was at the forefront in developing the innovative artesunate vaccine, Artsun, the first of its kind, to replace quinine injections. The WHO has compared it to the "gold standard" in the battle against malaria.

Artsun is now registered in more than 30 countries and regions and has a 90 percent market share in treating servere malaria.

During the past three years, GPSC has supplied 23.8 million units of the vaccine globally, saving more than 3.4 million people from the scourge of malaria.

"This is an innovative drug that was developed in China," Guo Guangchang, chairman of Fosun Group, said.

During the past decade, 13 anti-malaria drugs developed by GPSC have been approved by the WHO, including three which are injected and 10 in oral tablets.

The company's products account for 80 percent of China's anti-malaria drug exports.

In the first three quarters of this year, Fosun Pharmaceutical, which includes GPSC, reported revenue of 9 billion yuan ($1.41 billion), a rise of 4.76 percent compared to the same period in 2014.

Further financial details have yet to be released. The company's products include metabolism and digestive system drugs, and vaccines, as well as GPSC's brands.

"At present, Guilin Pharma is building a new manufacturing site which will comply with (international) standards," GPSC said.

"In future, we will have a production capacity of over 15 billion tablets/capsules per year to meet the needs of both domestic and global markets." the company added.

Fosun Pharmaceutical also plans to expand its research and development program by working alongside institutions and other organizations.

"There should be more cooperation with research institutes and organizations," Chen Qiyu, chairman of Fosun Pharmaceutical, said.

"This would help create a much larger platform, allowing us to do a better job globally."

Previous Page 1 2 Next Page

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 黄色大视频| 国产精品1区 | 永久免费在线看片视频 | 人人超碰人人 | 九热精品| 国产精品一区av | 欧美日韩中文视频 | 小草av | 亚洲久视频 | 国产一区二区三区视频在线播放 | 亚洲成人国产精品 | 国产精品视频专区 | 自拍偷拍一区 | 欧美丰满老妇 | 国内精品小视频 | 日本在线一区二区 | 91高清免费 | 伊人不卡| 狼窝色中色 | 欧美最猛黑人xxxx黑人猛交 | 国产一区免费在线观看 | 国产高清一区二区三区 | 久久精品二区 | 成人午夜免费在线观看 | 免费高清毛片 | 久久久国产精品免费 | 国产美女视频一区 | 精品久久久一区二区 | 国产精品毛片一区二区三区 | 日韩在线精品视频 | 久久久久亚洲精品 | 久久精品一二区 | 影音先锋男人天堂 | 日韩欧美在线观看 | 97在线观看视频免费 | 国产精品视频在 | 欧美顶级毛片在线播放 | 欧美日韩精品免费 | 蜜臀av性久久久久蜜臀aⅴ四虎 | 一区在线看| 肉丝av|